ASTERDM767.95

Aster DM Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSCOHANCEWOCKPHARMASYNGENEGLANDLALPATHLABMcap ₹39,790 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ASTERDM
FY26
APOLLOHOSP
FY26
MAXHEALTH
FY26
KIMS
FY26
Peer
Median
Valuation — at last close
P/E101.99×65.86×69.66×128.36×69.66× +46%
P/B8.23×12.82×9.36×12.10×12.10× -32%
EV/EBITDA44.68×34.95×46.08×42.56×42.56× +5%
Market Cap₹39,790 Cr₹1.28L Cr₹1.01L Cr₹30,960 Cr₹1.01L Cr -60%
Growth
Revenue CAGR 3Y-26.99%14.94%22.43%21.12%21.12% -228%
Revenue CAGR 5Y-11.61%19.03%27.30%24.04%24.04% -148%
Net Income CAGR 3Y-3.51%33.35%9.34%-12.87%9.34% -138%
Revenue YoY (latest Q)21.60%20.56%16.70%35.33%20.56% +5%
Net Income YoY (latest Q)-68.70%38.41%4.87%-56.00%4.87% -1511%
Profitability
EBITDA Margin19.41%14.94%26.79%20.54%20.54% -6%
Net Income Margin9.20%7.94%17.23%6.20%7.94% +16%
Return on Common Equity8.03%19.47%13.42%9.44%13.42% -40%
Return on Capital Employed8.93%18.41%11.94%7.96%11.94% -25%
Return on Assets5.27%9.02%8.37%3.12%8.37% -37%
Credit & Quality
Total Debt/Equity0.15×0.57×0.32×1.27×0.57× -74%
Interest Coverage5.18×6.44×7.64×2.56×6.44× -20%
Scale — latest FY
Revenue / Total Income₹4,643 Cr₹25,229 Cr₹8,373 Cr₹3,905 Cr₹8,373 Cr -45%
Net Income₹427 Cr₹2,003 Cr₹1,442 Cr₹242 Cr₹1,442 Cr -70%
Total Assets₹8,112 Cr₹22,197 Cr₹17,231 Cr₹7,759 Cr₹17,231 Cr -53%
EPS₹7.53₹135.04₹14.83₹6.03₹14.83 -49%
Book Value per Share₹93.29₹693.64₹110.43₹63.96₹110.43 -16%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.